Amphastar Pharmaceuticals, Inc.
Ticker: 1297184
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 171.17-10.8% | 191.84+10.0% | 174.41+2.3% | 170.53-10.8% | 191.21+4.8% | 182.39+6.1% | 171.84-4.8% | 180.56 |
| Total Income | 171.17-10.8% | 191.84+10.0% | 174.41+2.3% | 170.53-10.8% | 191.21+4.8% | 182.39+6.1% | 171.84-4.8% | 180.56 |
| EXPENSES | ||||||||
| Expenditure | 157.54-5.4% | 166.52+25.9% | 132.23-0.8% | 133.24-0.7% | 134.17+5.5% | 127.18+2.7% | 123.83+14.8% | 107.88 |
| Tax | 3.63-12.7% | 4.16-49.9% | 8.31+48.9% | 5.58-23.0% | 7.25-41.0% | 12.29+197.6% | 4.13-70.6% | 14.03 |
| PROFIT | ||||||||
| PBT | 10.05-53.3% | 21.51-45.3% | 39.34+27.5% | 30.86-35.3% | 47.68-5.1% | 50.24+4.9% | 47.88-24.8% | 63.64 |
| Net Profit | 6.42-63.0% | 17.35-44.1% | 31.03+22.7% | 25.29-37.4% | 40.43+6.5% | 37.95-12.1% | 43.18-12.3% | 49.22 |
| KEY METRICS | ||||||||
| OPM % | 7.96%-5.24pp | 13.20%-10.99pp | 24.19%+2.32pp | 21.87%-7.97pp | 29.84%-0.44pp | 30.27%+2.33pp | 27.94%-12.31pp | 40.25% |
| NPM % | 3.75%-5.29pp | 9.04%-8.75pp | 17.79%+2.96pp | 14.83%-6.32pp | 21.14%+0.34pp | 20.81%-4.32pp | 25.13%-2.13pp | 27.26% |
| EPS | 0.14-63.2% | 0.38-42.4% | 0.66+24.5% | 0.53-36.1% | 0.83+7.8% | 0.77-14.4% | 0.90-10.9% | 1.01 |
Corporate Events
Board MeetingAMPH
20261Jun
Board Meeting
Annual Meeting of Stockholders to elect three Class I direct…
SEC Filing ↗